Journal of Medical Case Reports · 2019 · 17 citations · 5 references
MedicineImmunologyOncologyImmunopathologyImmunotherapyMetastasisAutoimmune VasculitisCancer ImmunotherapyImmune-mediated Renal DiseaseImmune-related Adverse EventsImmunotherapy For Genitourinary CancersAntibody-mediated ToxicityCutaneous Leukocytoclastic VasculitisDrug-induced PurpuraEpidermal Growth Factor Receptor InhibitionRenal Involvement In VasculitisRenal VasculitisSkin Manifestations Of VasculitisVasculitis Complications
BACKGROUND: Panitumumab is the first human combinatorial antibody for the treatment of metastatic colorectal carcinoma. Dermatologic toxicity of all grades occurs in more than 90% of patients. However, there are few reports of purpura induced by anti-epidermal growth factor receptor antibody. Renal failure is also uncommon as an adverse event of anti-epidermal growth factor receptor antibody. CASE PRESENTATION: A 67-year-old Japanese man with advanced colon cancer received monotherapy with panitumumab. General malaise, bilateral edema of his legs, and bilateral purpura of his forearms developed 2 days after the second cycle of panitumumab. A skin biopsy was performed to evaluate the purpuric lesions on his left leg and leukocytoclastic vasculitis was diagnosed. Blood tests showed grade III acute renal failure with a blood urea nitrogen level of 33.8 mg/dL and a creatinine level of 3.10 mg/dL. CONCLUSIONS: This is the first reported case of leukocytoclastic vasculitis followed by purpura and acute renal failure associated with panitumumab.
5
Ryuichiro Kumasaka, Norio Nakamura, K Shirato et al. · Journal of Clinical Oncology · 2004 · 49 citations · Full text
Crescentic glomerulonephritis in a patient with advanced lung cancer during erlotinib therapy
Noriaki Kurita, Naobumi Mise, A Fujii et al. · Clinical Kidney Journal · 2009 · 14 citations · Full text
Medicine, Nephrology, Oncology +17
Cetuximab-induced nephrotic syndrome in a case of metastatic rectal cancer
Chiharu Ito, Hirofumi Fujii, Manabu Ogura et al. · Journal of Oncology Pharmacy Practice · 2012 · 11 citations
Medicine, Oncology, Pharmacology +14